vs
Side-by-side financial comparison of Applied Therapeutics, Inc. (APLT) and Ivanhoe Electric Inc. (IE). Click either name above to swap in a different company.
Applied Therapeutics, Inc. is the larger business by last-quarter revenue ($1.0M vs $896.0K, roughly 1.1× Ivanhoe Electric Inc.). Applied Therapeutics, Inc. runs the higher net margin — -1899.0% vs -4500.4%, a 2601.4% gap on every dollar of revenue. On growth, Applied Therapeutics, Inc. posted the faster year-over-year revenue change (719.7% vs -32.7%).
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in 2016.
Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.
APLT vs IE — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0M | $896.0K |
| Net Profit | $-19.0M | $-40.3M |
| Gross Margin | — | 69.5% |
| Operating Margin | -1675.8% | -4167.7% |
| Net Margin | -1899.0% | -4500.4% |
| Revenue YoY | 719.7% | -32.7% |
| Net Profit YoY | 72.3% | -318.3% |
| EPS (diluted) | $-0.13 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $896.0K | ||
| Q3 25 | $1.0M | $545.0K | ||
| Q2 25 | $0 | $1.1M | ||
| Q1 25 | $0 | $735.0K | ||
| Q4 24 | $-1.0K | $1.3M | ||
| Q3 24 | — | $671.0K | ||
| Q2 24 | $144.0K | $538.0K | ||
| Q1 24 | $190.0K | $360.0K |
| Q4 25 | — | $-40.3M | ||
| Q3 25 | $-19.0M | $-17.5M | ||
| Q2 25 | $-21.3M | $-23.9M | ||
| Q1 25 | $-21.8M | $-34.1M | ||
| Q4 24 | $44.0M | $18.5M | ||
| Q3 24 | — | $-43.2M | ||
| Q2 24 | $2.9M | $-46.8M | ||
| Q1 24 | $-83.9M | $-60.1M |
| Q4 25 | — | 69.5% | ||
| Q3 25 | — | 51.2% | ||
| Q2 25 | — | 72.5% | ||
| Q1 25 | — | 60.1% | ||
| Q4 24 | — | 64.7% | ||
| Q3 24 | — | 61.8% | ||
| Q2 24 | — | 64.3% | ||
| Q1 24 | — | 72.2% |
| Q4 25 | — | -4167.7% | ||
| Q3 25 | -1675.8% | -4328.3% | ||
| Q2 25 | — | -2400.3% | ||
| Q1 25 | — | -3674.0% | ||
| Q4 24 | 3302300.0% | -2229.4% | ||
| Q3 24 | — | -6233.8% | ||
| Q2 24 | -14194.4% | -9023.4% | ||
| Q1 24 | -11101.6% | -15800.3% |
| Q4 25 | — | -4500.4% | ||
| Q3 25 | -1899.0% | -3214.9% | ||
| Q2 25 | — | -2233.2% | ||
| Q1 25 | — | -4645.0% | ||
| Q4 24 | -4400700.0% | 1386.6% | ||
| Q3 24 | — | -6443.5% | ||
| Q2 24 | 2012.5% | -8695.7% | ||
| Q1 24 | -44177.9% | -16693.1% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-0.13 | $0.13 | ||
| Q2 25 | $-0.15 | $0.18 | ||
| Q1 25 | $-0.15 | $0.24 | ||
| Q4 24 | $0.52 | $-0.14 | ||
| Q3 24 | — | $0.36 | ||
| Q2 24 | $-0.13 | $0.39 | ||
| Q1 24 | $-0.67 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.9M | $173.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-561.0K | $416.1M |
| Total Assets | $34.4M | $483.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $173.3M | ||
| Q3 25 | $11.9M | $69.5M | ||
| Q2 25 | $30.4M | $88.0M | ||
| Q1 25 | $50.8M | $98.2M | ||
| Q4 24 | $79.4M | $41.0M | ||
| Q3 24 | — | $81.1M | ||
| Q2 24 | $122.2M | $133.8M | ||
| Q1 24 | $146.5M | $179.4M |
| Q4 25 | — | $416.1M | ||
| Q3 25 | $-561.0K | $280.1M | ||
| Q2 25 | $17.4M | $293.3M | ||
| Q1 25 | $36.7M | $307.0M | ||
| Q4 24 | $57.0M | $268.6M | ||
| Q3 24 | — | $250.1M | ||
| Q2 24 | $72.4M | $289.2M | ||
| Q1 24 | $67.3M | $331.5M |
| Q4 25 | — | $483.3M | ||
| Q3 25 | $34.4M | $386.2M | ||
| Q2 25 | $37.3M | $400.5M | ||
| Q1 25 | $56.9M | $414.4M | ||
| Q4 24 | $86.7M | $374.9M | ||
| Q3 24 | — | $375.4M | ||
| Q2 24 | $127.8M | $416.3M | ||
| Q1 24 | $151.2M | $461.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.4M | $-25.7M |
| Free Cash FlowOCF − Capex | — | $-25.7M |
| FCF MarginFCF / Revenue | — | -2872.8% |
| Capex IntensityCapex / Revenue | — | 4.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-90.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.7M | ||
| Q3 25 | $-18.4M | $-27.7M | ||
| Q2 25 | $-20.3M | $-20.0M | ||
| Q1 25 | $-28.6M | $-15.8M | ||
| Q4 24 | $-19.5M | $-30.7M | ||
| Q3 24 | — | $-36.9M | ||
| Q2 24 | $-22.6M | $-44.5M | ||
| Q1 24 | $-18.9M | $-50.0M |
| Q4 25 | — | $-25.7M | ||
| Q3 25 | — | $-27.8M | ||
| Q2 25 | — | $-21.3M | ||
| Q1 25 | — | $-15.8M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | — | $-36.9M | ||
| Q2 24 | — | $-45.0M | ||
| Q1 24 | — | $-50.6M |
| Q4 25 | — | -2872.8% | ||
| Q3 25 | — | -5103.9% | ||
| Q2 25 | — | -1990.1% | ||
| Q1 25 | — | -2146.5% | ||
| Q4 24 | — | -2432.4% | ||
| Q3 24 | — | -5506.6% | ||
| Q2 24 | — | -8372.9% | ||
| Q1 24 | — | -14064.2% |
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 16.9% | ||
| Q2 25 | — | 117.6% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 127.3% | ||
| Q3 24 | — | 8.8% | ||
| Q2 24 | — | 93.7% | ||
| Q1 24 | — | 186.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.44× | -1.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | -7.80× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
